| Bioactivity | Rivoglitazone hydrochloride (R-106056 hydrochloride) is a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist. Rivoglitazone hydrochloride (R-106056 hydrochloride) exerts its anti-diabetic effect by activating PPARγ to regulate the expression of a large number of genes related to lipid and glucose metabolism. Rivoglitazone hydrochloride (R-106056 hydrochloride) can be used to study insulin secretion and insulin resistance in animal models of diabetes[1]. |
| CAS | 299176-11-7 |
| Formula | C20H20ClN3O4S |
| Molar Mass | 433.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kanda S, et al. Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator–Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models[J]. Journal of pharmacological sciences, 2009, 111(2): 155-166. |
Rivoglitazone hydrochloride
CAS: 299176-11-7 F: C20H20ClN3O4S W: 433.91
Rivoglitazone hydrochloride (R-106056 hydrochloride) is a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonis
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.